Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Low-cost diagnostic test for susceptible and drug-resistant tuberculosis in rural Malawi.

Zhang A, Jumbe E, Krysiak R, Sidiki S, Kelley HV, Chemey EK, Kamba C, Mwapasa V, García JI, Norris A, Pan XJ, Evans C, Wang SH, Kwiek JJ, Torrelles JB.

Afr J Lab Med. 2018 Jun 4;7(1):690. doi: 10.4102/ajlm.v7i1.690. eCollection 2018.

2.

Pharmacokinetics of Piperaquine and Safety Profile of Dihydroartemisinin-Piperaquine Coadministered with Antiretroviral Therapy in Malaria-Uninfected HIV-Positive Malawian Adults.

Banda CG, Dzinjalamala F, Mukaka M, Mallewa J, Maiden V, Terlouw DJ, Lalloo DG, Khoo SH, Mwapasa V.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00634-18. doi: 10.1128/AAC.00634-18. Print 2018 Aug.

3.

Pharmacokinetics and Safety Profile of Artesunate-Amodiaquine Coadministered with Antiretroviral Therapy in Malaria-Uninfected HIV-Positive Malawian Adults.

Banda CG, Dzinjalamala F, Mukaka M, Mallewa J, Maiden V, Terlouw DJ, Lalloo DG, Khoo SH, Mwapasa V.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00412-18. doi: 10.1128/AAC.00412-18. Print 2018 Jul.

4.

Analysis of rural health centres preparedness for the management of diabetic patients in Malawi.

Chikowe I, Mwapasa V, Kengne AP.

BMC Res Notes. 2018 May 2;11(1):267. doi: 10.1186/s13104-018-3369-7.

5.

Supporting capacity for research on malaria in Africa.

Greenwood B, Gaye O, Kamya MR, Kibiki G, Mwapasa V, Phiri KS, Tagbor H, Terlouw D, Bates I, Craig A, Magnussen P, Theander TG, Bhasin A, McCullough H, Schellenberg D.

BMJ Glob Health. 2018 Apr 12;3(2):e000723. doi: 10.1136/bmjgh-2018-000723. eCollection 2018.

6.

Malaria in pregnancy alters l-arginine bioavailability and placental vascular development.

McDonald CR, Cahill LS, Gamble JL, Elphinstone R, Gazdzinski LM, Zhong KJY, Philson AC, Madanitsa M, Kalilani-Phiri L, Mwapasa V, Ter Kuile FO, Sled JG, Conroy AL, Kain KC.

Sci Transl Med. 2018 Mar 7;10(431). pii: eaan6007. doi: 10.1126/scitranslmed.aan6007.

PMID:
29514999
7.

Assessment of Efficacy and Safety of Arterolane Maleate-Piperaquine Phosphate Dispersible Tablets in Comparison With Artemether-Lumefantrine Dispersible Tablets in Pediatric Patients With Acute Uncomplicated Plasmodium falciparum Malaria: A Phase 3, Randomized, Multicenter Trial in India and Africa.

Toure OA, Mwapasa V, Sagara I, Gaye O, Thompson R, Maheshwar AV, Mishra P, Behra N, Tshefu AK, Das RR, Anvikar AR, Sharma P, Roy A, Sharma SK, Nasa A, Jalali RK, Valecha N; Arterolane Maleate-Piperaquine Phosphate (AM-PQP) Study Team.

Clin Infect Dis. 2017 Oct 30;65(10):1711-1720. doi: 10.1093/cid/cix617.

PMID:
29020247
8.

Changing times? Gender roles and relationships in maternal, newborn and child health in Malawi.

Manda-Taylor L, Mwale D, Phiri T, Walsh A, Matthews A, Brugha R, Mwapasa V, Byrne E.

BMC Pregnancy Childbirth. 2017 Sep 25;17(1):321. doi: 10.1186/s12884-017-1523-1.

9.

Qualitative study to develop processes and tools for the assessment and tracking of African institutions' capacity for operational health research.

Wallis S, Cole DC, Gaye O, Mmbaga BT, Mwapasa V, Tagbor H, Bates I.

BMJ Open. 2017 Sep 5;7(9):e016660. doi: 10.1136/bmjopen-2017-016660.

10.

Increased risk of low birth weight in women with placental malaria associated with P. falciparum VAR2CSA clade.

Patel JC, Hathaway NJ, Parobek CM, Thwai KL, Madanitsa M, Khairallah C, Kalilani-Phiri L, Mwapasa V, Massougbodji A, Fievet N, Bailey JA, Ter Kuile FO, Deloron P, Engel SM, Taylor SM, Juliano JJ, Tuikue Ndam N, Meshnick SR.

Sci Rep. 2017 Aug 11;7(1):7768. doi: 10.1038/s41598-017-04737-y.

11.

Malaria, malnutrition, and birthweight: A meta-analysis using individual participant data.

Cates JE, Unger HW, Briand V, Fievet N, Valea I, Tinto H, D'Alessandro U, Landis SH, Adu-Afarwuah S, Dewey KG, Ter Kuile FO, Desai M, Dellicour S, Ouma P, Gutman J, Oneko M, Slutsker L, Terlouw DJ, Kariuki S, Ayisi J, Madanitsa M, Mwapasa V, Ashorn P, Maleta K, Mueller I, Stanisic D, Schmiegelow C, Lusingu JPA, van Eijk AM, Bauserman M, Adair L, Cole SR, Westreich D, Meshnick S, Rogerson S.

PLoS Med. 2017 Aug 8;14(8):e1002373. doi: 10.1371/journal.pmed.1002373. eCollection 2017 Aug.

12.

Minimal Impact by Antenatal Subpatent Plasmodium falciparum Infections on Delivery Outcomes in Malawian Women: A Cohort Study.

Taylor SM, Madanitsa M, Thwai KL, Khairallah C, Kalilani-Phiri L, van Eijk AM, Mwapasa V, Ter Kuile FO, Meshnick SR.

J Infect Dis. 2017 Aug 1;216(3):296-304. doi: 10.1093/infdis/jix304.

13.

Modeling the Impact of Retention Interventions on Mother-to-Child Transmission of HIV: Results From INSPIRE Studies in Malawi, Nigeria, and Zimbabwe.

McCarthy E, Joseph J, Foster G, Mangwiro AZ, Mwapasa V, Oyeledun B, Phiri S, Sam-Agudu NA, Essajee S.

J Acquir Immune Defic Syndr. 2017 Jun 1;75 Suppl 2:S233-S239. doi: 10.1097/QAI.0000000000001364.

14.

Integrating HIV and Maternal, Neonatal and Child Health Services in Rural Malawi: An Evaluation of the Implementation Processes and Challenges.

Gunda A, Jousset A, Tchereni T, Joseph J, Mwapasa V.

J Acquir Immune Defic Syndr. 2017 Jun 1;75 Suppl 2:S132-S139. doi: 10.1097/QAI.0000000000001367.

PMID:
28498182
15.

Impact of Mother-Infant Pair Clinics and Short-Text Messaging Service (SMS) Reminders on Retention of HIV-Infected Women and HIV-Exposed Infants in eMTCT Care in Malawi: A Cluster Randomized Trial.

Mwapasa V, Joseph J, Tchereni T, Jousset A, Gunda A.

J Acquir Immune Defic Syndr. 2017 Jun 1;75 Suppl 2:S123-S131. doi: 10.1097/QAI.0000000000001340.

PMID:
28498181
16.

Four artemisinin-based treatments in African pregnant women with malaria.

PREGACT Study Group, Pekyi D, Ampromfi AA, Tinto H, Traoré-Coulibaly M, Tahita MC, Valéa I, Mwapasa V, Kalilani-Phiri L, Kalanda G, Madanitsa M, Ravinetto R, Mutabingwa T, Gbekor P, Tagbor H, Antwi G, Menten J, De Crop M, Claeys Y, Schurmans C, Van Overmeir C, Thriemer K, Van Geertruyden JP, D'Alessandro U, Nambozi M, Mulenga M, Hachizovu S, Kabuya JB, Mulenga J.

Malawi Med J. 2016 Sep;28(3):139-149.

17.

Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi.

Almond D, Madanitsa M, Mwapasa V, Kalilani-Phiri L, Webster J, Ter Kuile F, Paintain L.

Malar J. 2016 Nov 28;15(1):574.

18.

Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial.

Madanitsa M, Kalilani L, Mwapasa V, van Eijk AM, Khairallah C, Ali D, Pace C, Smedley J, Thwai KL, Levitt B, Wang D, Kang'ombe A, Faragher B, Taylor SM, Meshnick S, Ter Kuile FO.

PLoS Med. 2016 Sep 13;13(9):e1002124. doi: 10.1371/journal.pmed.1002124. eCollection 2016 Sep.

19.

Rapid Diagnostic Test Performance Assessed Using Latent Class Analysis for the Diagnosis of Plasmodium falciparum Placental Malaria.

Liu Y, Mwapasa V, Khairallah C, Thwai KL, Kalilani-Phiri L, Ter Kuile FO, Meshnick SR, Taylor SM.

Am J Trop Med Hyg. 2016 Oct 5;95(4):835-839. Epub 2016 Aug 15.

20.

Is using multiple imputation better than complete case analysis for estimating a prevalence (risk) difference in randomized controlled trials when binary outcome observations are missing?

Mukaka M, White SA, Terlouw DJ, Mwapasa V, Kalilani-Phiri L, Faragher EB.

Trials. 2016 Jul 22;17:341. doi: 10.1186/s13063-016-1473-3.

21.

The use of technology enhanced learning in health research capacity development: lessons from a cross country research partnership.

Byrne E, Donaldson L, Manda-Taylor L, Brugha R, Matthews A, MacDonald S, Mwapasa V, Petersen M, Walsh A.

Global Health. 2016 May 10;12(1):19. doi: 10.1186/s12992-016-0154-z.

22.

Absence of Association Between Sickle Trait Hemoglobin and Placental Malaria Outcomes.

Patel JC, Mwapasa V, Kalilani L, Ter Kuile FO, Khairallah C, Thwai KL, Meshnick SR, Taylor SM.

Am J Trop Med Hyg. 2016 May 4;94(5):1002-7. doi: 10.4269/ajtmh.15-0672. Epub 2016 Mar 21.

23.

Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.

PREGACT Study Group, Pekyi D, Ampromfi AA, Tinto H, Traoré-Coulibaly M, Tahita MC, Valéa I, Mwapasa V, Kalilani-Phiri L, Kalanda G, Madanitsa M, Ravinetto R, Mutabingwa T, Gbekor P, Tagbor H, Antwi G, Menten J, De Crop M, Claeys Y, Schurmans C, Van Overmeir C, Thriemer K, Van Geertruyden JP, D'Alessandro U, Nambozi M, Mulenga M, Hachizovu S, Kabuya JB, Mulenga J.

N Engl J Med. 2016 Mar 10;374(10):913-27. doi: 10.1056/NEJMoa1508606.

24.

A Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether-Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and Africa.

Toure OA, Valecha N, Tshefu AK, Thompson R, Krudsood S, Gaye O, Rao BHK, Sagara I, Bose TK, Mohanty S, Rao BS, Anvikar AR, Mwapasa V, Noedl H, Arora S, Roy A, Iyer SS, Sharma P, Saha N, Jalali RK; AM–PQP Study Team, Tiacoh L, Enosse S, Tangpukdee N, Kokolomami J, Ndiaye JL, Rao D, Yumva NN, Sidibe B, Mohanty R, Jha AC, Nyirenda M, Starzengruber P, Swoboda P.

Clin Infect Dis. 2016 Apr 15;62(8):964-971. doi: 10.1093/cid/ciw029. Epub 2016 Feb 21.

25.

A pilot study to determine the normal haematological indices for young Malawian adults in Blantyre, Malawi.

Chisale MR, Kumwenda P, Ngwira M, M'baya B, Chosamata BI, Mwapasa V.

Malawi Med J. 2015 Sep;27(3):96-100.

26.

Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trial.

Nambozi M, Mulenga M, Halidou T, Tagbor H, Mwapasa V, Phiri LK, Kalanda G, Valea I, Traore M, Mwakazanga D, Claeys Y, Schurmans C, De Crop M, Menten J, Ravinetto R, Thriemer K, Van Geertruyden JP, Mutabingwa T, D'Alessandro U; Pregact Group.

Reprod Health. 2015 Jan 15;12:5. doi: 10.1186/1742-4755-12-5.

27.

Mother-infant pair clinic and SMS messaging as innovative strategies for improving access to and retention in eMTCT care and Option B+ in Malawi: a cluster randomized control trial (the PRIME study).

Mwapasa V, Pro G, Chinkhumba J, Mukaka M, Kobayashi E, Stuart A, Gunda A, Joseph J, Sugandhi N, Chimbwandira FM, Eliya M.

J Acquir Immune Defic Syndr. 2014 Nov 1;67 Suppl 2:S120-4. doi: 10.1097/QAI.0000000000000327.

PMID:
25310117
28.

Independent lineages of highly sulfadoxine-resistant Plasmodium falciparum haplotypes, eastern Africa.

Taylor SM, Antonia AL, Harrington WE, Goheen MM, Mwapasa V, Chaluluka E, Fried M, Kabyemela E, Madanitsa M, Khairallah C, Kalilani-Phiri L, Tshefu AK, Rogerson SJ, Ter Kuile FO, Duffy PE, Meshnick SR.

Emerg Infect Dis. 2014 Jul;20(7):1140-8. doi: 10.3201/eid2007.131720.

29.

Cohort Profile: The Malawi Longitudinal Study of Families and Health (MLSFH).

Kohler HP, Watkins SC, Behrman JR, Anglewicz P, Kohler IV, Thornton RL, Mkandawire J, Honde H, Hawara A, Chilima B, Bandawe C, Mwapasa V, Fleming P, Kalilani-Phiri L.

Int J Epidemiol. 2015 Apr;44(2):394-404. doi: 10.1093/ije/dyu049. Epub 2014 Mar 16.

30.

Severity of maternal HIV-1 disease is associated with adverse birth outcomes in Malawian women: a cohort study.

Turner AN, Tabbah S, Mwapasa V, Rogerson SJ, Meshnick SR, Ackerman WE 4th, Kwiek JJ.

J Acquir Immune Defic Syndr. 2013 Dec 1;64(4):392-9. doi: 10.1097/QAI.0b013e3182a2d13c.

31.

Genotypic and phenotypic heterogeneity in the U3R region of HIV type 1 subtype C.

Mates JM, Kumar SB, Bazan J, Mefford M, Voronkin I, Handelman S, Mwapasa V, Ackerman W 4th, Janies D, Kwiek JJ.

AIDS Res Hum Retroviruses. 2014 Jan;30(1):102-12. doi: 10.1089/AID.2013.0026. Epub 2013 Aug 12.

32.

Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants.

Fouda GG, Mahlokozera T, Salazar-Gonzalez JF, Salazar MG, Learn G, Kumar SB, Dennison SM, Russell E, Rizzolo K, Jaeger F, Cai F, Vandergrift NA, Gao F, Hahn B, Shaw GM, Ochsenbauer C, Swanstrom R, Meshnick S, Mwapasa V, Kalilani L, Fiscus S, Montefiori D, Haynes B, Kwiek J, Alam SM, Permar SR.

Retrovirology. 2013 Jan 10;10:3. doi: 10.1186/1742-4690-10-3.

33.

How countries cope with competing demands and expectations: perspectives of different stakeholders on priority setting and resource allocation for health in the era of HIV and AIDS.

Jenniskens F, Tiendrebeogo G, Coolen A, Blok L, Kouanda S, Sataru F, Ralisimalala A, Mwapasa V, Kiyombo M, Plummer D.

BMC Public Health. 2012 Dec 11;12:1071. doi: 10.1186/1471-2458-12-1071.

34.

The effect of HIV infection on the risk, frequency, and intensity of Plasmodium falciparum parasitemia in primigravid and multigravid women in Malawi.

Nkhoma ET, Bowman NM, Kalilani-Phiri L, Mwapasa V, Rogerson SJ, Meshnick SR.

Am J Trop Med Hyg. 2012 Dec;87(6):1022-7. doi: 10.4269/ajtmh.2012.12-0392. Epub 2012 Oct 8.

35.

Effect of HIV infection and Plasmodium falciparum parasitemia on pregnancy outcomes in Malawi.

Nkhoma ET, Kalilani-Phiri L, Mwapasa V, Rogerson SJ, Meshnick SR.

Am J Trop Med Hyg. 2012 Jul;87(1):29-34. doi: 10.4269/ajtmh.2012.11-0380.

36.

Transactional sex and HIV: understanding the gendered structural drivers of HIV in fishing communities in Southern Malawi.

MacPherson EE, Sadalaki J, Njoloma M, Nyongopa V, Nkhwazi L, Mwapasa V, Lalloo DG, Desmond N, Seeley J, Theobald S.

J Int AIDS Soc. 2012 Jun 14;15 Suppl 1:1-9. doi: 10.7448/IAS.15.3.17364.

37.

Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study.

Taylor SM, Antonia AL, Chaluluka E, Mwapasa V, Feng G, Molyneux ME, ter Kuile FO, Meshnick SR, Rogerson SJ.

Clin Infect Dis. 2012 Jul;55(1):42-50. doi: 10.1093/cid/cis301. Epub 2012 Mar 22.

38.

Elevated cytokine and chemokine levels in the placenta are associated with in-utero HIV-1 mother-to-child transmission.

Kumar SB, Rice CE, Milner DA Jr, Ramirez NC, Ackerman WE 4th, Mwapasa V, Turner AN, Kwiek JJ.

AIDS. 2012 Mar 27;26(6):685-94. doi: 10.1097/QAD.0b013e3283519b00.

39.

Adaptive evolution and fixation of drug-resistant Plasmodium falciparum genotypes in pregnancy-associated malaria: 9-year results from the QuEERPAM study.

Taylor SM, Antonia A, Feng G, Mwapasa V, Chaluluka E, Molyneux M, ter Kuile FO, Rogerson SJ, Meshnick SR.

Infect Genet Evol. 2012 Mar;12(2):282-90. doi: 10.1016/j.meegid.2011.11.006. Epub 2011 Nov 20.

40.

The uptake and accuracy of oral kits for HIV self-testing in high HIV prevalence setting: a cross-sectional feasibility study in Blantyre, Malawi.

Choko AT, Desmond N, Webb EL, Chavula K, Napierala-Mavedzenge S, Gaydos CA, Makombe SD, Chunda T, Squire SB, French N, Mwapasa V, Corbett EL.

PLoS Med. 2011 Oct;8(10):e1001102. doi: 10.1371/journal.pmed.1001102. Epub 2011 Oct 4.

41.
42.

Antibodies that induce phagocytosis of malaria infected erythrocytes: effect of HIV infection and correlation with clinical outcomes.

Ataíde R, Mwapasa V, Molyneux ME, Meshnick SR, Rogerson SJ.

PLoS One. 2011;6(7):e22491. doi: 10.1371/journal.pone.0022491. Epub 2011 Jul 19.

43.

The genetic bottleneck in vertical transmission of subtype C HIV-1 is not driven by selection of especially neutralization-resistant virus from the maternal viral population.

Russell ES, Kwiek JJ, Keys J, Barton K, Mwapasa V, Montefiori DC, Meshnick SR, Swanstrom R.

J Virol. 2011 Aug;85(16):8253-62. doi: 10.1128/JVI.00197-11. Epub 2011 May 18.

44.

Different regions of HIV-1 subtype C env are associated with placental localization and in utero mother-to-child transmission.

Kumar SB, Handelman SK, Voronkin I, Mwapasa V, Janies D, Rogerson SJ, Meshnick SR, Kwiek JJ.

J Virol. 2011 Jul;85(14):7142-52. doi: 10.1128/JVI.01955-10. Epub 2011 May 4.

45.

Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi.

Kapito-Tembo A, Meshnick SR, van Hensbroek MB, Phiri K, Fitzgerald M, Mwapasa V.

J Infect Dis. 2011 Feb 15;203(4):464-72. doi: 10.1093/infdis/jiq072. Epub 2011 Jan 7.

46.

Exposing malaria in-host diversity and estimating population diversity by capture-recapture using massively parallel pyrosequencing.

Juliano JJ, Porter K, Mwapasa V, Sem R, Rogers WO, Ariey F, Wongsrichanalai C, Read A, Meshnick SR.

Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20138-43. doi: 10.1073/pnas.1007068107. Epub 2010 Nov 1.

47.

Using a simplified human immunodeficiency virus type 1 p24 antigen assay to diagnose pediatric HIV-infection in Malawi.

Mwapasa V, Cachafeiro A, Makuta Y, Beckstead DJ, Pennell ML, Chilima B, Mwagomba B, Fiscus SA, Kwiek JJ.

J Clin Virol. 2010 Dec;49(4):299-302. doi: 10.1016/j.jcv.2010.08.013. Epub 2010 Sep 19.

48.

Health workforce responses to global health initiatives funding: a comparison of Malawi and Zambia.

Brugha R, Kadzandira J, Simbaya J, Dicker P, Mwapasa V, Walsh A.

Hum Resour Health. 2010 Aug 11;8:19. doi: 10.1186/1478-4491-8-19.

49.

Using an improved phagocytosis assay to evaluate the effect of HIV on specific antibodies to pregnancy-associated malaria.

Ataíde R, Hasang W, Wilson DW, Beeson JG, Mwapasa V, Molyneux ME, Meshnick SR, Rogerson SJ.

PLoS One. 2010 May 25;5(5):e10807. doi: 10.1371/journal.pone.0010807.

50.

A whole genome association study of mother-to-child transmission of HIV in Malawi.

Joubert BR, Lange EM, Franceschini N, Mwapasa V, North KE, Meshnick SR; NIAID Center for HIV/AIDS Vaccine Immunology.

Genome Med. 2010 Mar 1;2(3):17. doi: 10.1186/gm138. eCollection 2010. Erratum in: Genome Med. 2010;2(10):76.

Supplemental Content

Loading ...
Support Center